[The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].
The 3rd part of the paper deals with the results of a combined revaccination against diphtheria and tetanus in a group of 25 children after allogeneic bone marrow transplantation (BMT) with and without graft versus host disease (GvHD) and after autologous transplantation. It can be shown that in the allogeneic transplanted groups with and without GvHD it is possible to build up a tetanus and diphtheria antitoxin titre in a safe protective cause by a 2nd basic immunisation consisting of 3 single vaccinations starting about 9 to 12 months later. For autologous transplanted children only 1 to 2 vaccinations at a later term than for the allogeneic transplanted children may possibly be sufficient.
Prager
J
J
Universitäts-Kinderklinik Jussuf Ibrahim, Jena.
Baumert
A
A
Thilo
W
W
Hermann
J
J
Fuchs
D
D
Sauerbrey
A
A
Zintl
F
F
D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D004166:Diphtheria Antitoxin / Q000032:analysis*; D004168:Diphtheria Toxoid / Q000276:immunology*; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D013743:Tetanus Antitoxin / Q000032:analysis*; D013745:Tetanus Toxoid / Q000276:immunology*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D004166:Diphtheria Antitoxin; D004168:Diphtheria Toxoid; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid
Untersuchungen zur Kinetik der Impfantikörper gegen Tetanustoxoid, Diphtherietoxoid, Masern-Virus, Poliomyelitis-Virus und Pneumokokken nach allogener und autologer Knochenmarktransplantation und Wiederholungsimpfung. Teil 3: Kinetik der Impfantikörper gegen Tetanustoxoid und Diphtherietoxoid nach allogener und autologer Knochenmarktransplantation und kombinierter Wiederholungsimpfung gegen Diphtherie und Tetanus.